http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003225052-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D229-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-20 |
filingDate | 2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceded95acb53d26c8ac4f0690e57d3d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf88abfa66083a1ad6b09a59c32faa1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3151e6a7f81c178e50bc9aa2bbdf3930 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37acc25eef9cab1e1c89d7c03e151a82 |
publicationDate | 2003-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2003225052-A1 |
titleOfInvention | Analogs of terpene trilactones from Ginkgo biloba and related compounds and uses thereof |
abstract | The subject invention provides compounds having the structure: n n n wherein R 1 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; R 2 is H, OH, a photoactivatable moiety, a fluorescent-moiety, or a radioactive moiety; R 3 is H or OH; R 4 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; and wherein at least one of R 1 , R 2 , R 3 , or R 4 is a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety, or an optically pure enantiomer of the compound or wherein R1 is H or OH; R2 is H, OH, halogen, unsubstituted or substituted, straight or branched (C 1 -C 5 ) alkyl group, (C 2 -C 5 ) alkenyl, or a (C 2 -C 5 ) alkynyl, (C 1 -C 5 ) alkoxy, (C 2 -C 5 ) alkenyloxy, or (C 2 -C 5 ) alkynyloxy, —N3, —COR5, —CONR5R6, —CO2R5, —OCOR5, —NH(OH), —NR5R6, —NHCOR5, —N(OH)COR5, —CH2OR5, —OCH2CO2R5, —CH2SR5, —CH2NR5R6, —SR5, —OSR5, or —NR5SO2R6, where R5 and R6 are each independently hydrogen, substituted or unsubstituted (C 1 -C 5 ) alkyl, (C 2 -C 5 ) alkenyl, or (C 2 -C 5 ) alkynyl, or a cycloalkyl or aryl group having 3 to 10 carbon atoms; R3 is H or OH; R4 is H, (C1-C10) alkyl, (C1-C10) alkenyl, (C1-C10) alkynyl, -A-Ar, -A-Z-Ar, —SO 2 —Ar, or -A-NR 5 , or —R 7 , where A, Z and Ar are as defined herein, and the use of the compounds for detecting or identifying a receptor which binds the compounds of the invention or for treating a PAF associated condition in a subject. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005119336-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007098632-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765196-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008306145-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014039202-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7429670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7763741-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7473788-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009221019-A1 |
priorityDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 547.